Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
Name
Alexis-2008-Factors Affecting the Clearance.pdf
Size
592.41 KB
Format
Adobe PDF
Checksum (MD5)
491e773a17e3609fd99a2ebbc52c5c22
Author(s)
Alexis, Frank
Molnar, Linda K.
Farokhzad, Omid C.
Pridgen, Eric M.
Date Issued
August 2008
Journal
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Citation
Alexis, Frank et al. “Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles.” Molecular Pharmaceutics 5.4 (2008): 505–515. © 2008 American Chemical Society
Version
Final published version
Abstract
Nanoparticle (NP) drug delivery systems (5−250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range. Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life. In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation. These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization. All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.
MIT Department
MIT-Harvard Center for Cancer Nanotechnology Excellence
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/mp800051m
